EMD is an actively-managed dollar-denominated emerging market debt leveraged CEF. Each adjective has important implications for shareholders. As EMD is actively-managed, performance is somewhat ...

A new line of China-exclusive Audi models is garnering interest in Europe, with car enthusiasts eying the sophisticated design and top-notch performance of the electric E5 Sportback. The model, part ...

Andy is a seasoned technology journalist with more than 15 years experience in the mobile industry, writing for Digital Trends, Wired, and more. During that time he has reviewed hundreds of ...

After a regulatory experiment with an exemption that was intended to help exempt market dealers (EMDs) participate in certain capital-raising efforts flopped, securities regulators are looking for ...

Cladribine capsules have the potential to be the first oral treatment for people living with rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia Gravis Cladribine capsules has ...

(RTTNews) - Microsoft (MSFT) is overhauling how security teams work by bringing Security Copilot's AI agents directly into Microsoft 365 E5. With cyberattacks accelerating and a global shortage of ...

Cigna and CVS Health are the latest organizations to take part in TrumpRx’s efforts to lower the cost of drugs to “most favored nation” pricing. Cigna, through its Evernorth pharmacies Freedom ...

Merck KGaA’s U.S. arm EMD Serono is joining President Donald Trump’s most-favored nation drug pricing push with an agreement to sell its fertility therapies at a sharp discount through the ...

On Thursday, President Donald Trump announced the third agreement with a pharmaceutical manufacturer to bring American drug prices in line with the lowest paid by other developed nations, known as the ...

President Donald Trump made an announcement Thursday from the Oval Office that EMD Serono will reduce the cost of fertility medication in effort to help make IVF more affordable. Watch Trump’s remarks ...

EMD Serono also entered an agreement with the U.S. secretary of commerce to exclude its pharmaceutical products and ingredients from Section 232 tariffs. To further expand therapeutic options for ...